<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The diagnosis of B-cell <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo> is a great challenge when made in a background of polyclonal B cells </plain></SENT>
<SENT sid="1" pm="."><plain>We studied the diagnostic usefulness of aberrant CD22 expression for differentiating neoplastic from benign B cells by 4-color flow cytometry </plain></SENT>
<SENT sid="2" pm="."><plain>Of 56 cases of B-cell <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0005523'>lymphoproliferative disorders</z:hpo>, we found that neoplastic cells showed aberrant CD22 expression in 39 (70%) of 56 cases, including <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, hairy cell <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>In 4 cases, monoclonality was detected definitively only by evaluating the immunoglobulin light chain restriction in B cells with aberrant CD22 expression because numerous polyclonal B cells were present </plain></SENT>
<SENT sid="4" pm="."><plain>Aberrant CD22 expression is a useful marker for detection of monoclonal B cells admixed with numerous benign polyclonal B cells </plain></SENT>
</text></document>